Rescue of cell cycle progression in BRAF inhibitor–resistant human melanoma by a chromatin modifier
The BRAF V600E -specific inhibitor vemurafenib blocks mitogen-activated protein kinase pathway and induces cell cycle arrest at G0/G1 phase leading to apoptosis of melanomas. To gain an understanding of the dynamics of cell cycle regulation during vemurafenib therapy, we analyzed several vemurafenib...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-09-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317721620 |